Allogene Therapeutics ALLO
NASDAQ ALLO
$1.60 -0.02 (-1.23%)
At close: Sep 30, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Shares Outstanding (Entity) (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) posted Shares Outstanding (Entity) of 345.35 million for Q2 2026, up 56.9% from 220.13 million a year earlier and up 41.1% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends

For FY2025, Allogene Therapeutics' Shares Outstanding (Entity) came in at 229.41 million, up 8.1% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for eight consecutive years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
  • In prior years, Allogene Therapeutics' Shares Outstanding (Entity) was 212.21 million in FY2024 (+25.8%), 168.64 million in FY2023 (+16.8%), 144.44 million in FY2022 (+1.3%) and 142.62 million in FY2021 (+1.5%).
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2018.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 27 quarters, with growth averaging 20.9% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.1% in Q3 2022 to 56.9% in Q2 2026.
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 244.82 million (Q1 2026), 229.41 million (Q4 2025) and 223.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Allogene Therapeutics 552.55 Mn 552.55 Mn - 345.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 345.35 Mn
Mar 31, 2026 244.82 Mn
Dec 31, 2025 229.41 Mn
Sep 30, 2025 223.16 Mn
Jun 30, 2025 220.13 Mn
Mar 31, 2025 218.60 Mn
Dec 31, 2024 212.21 Mn
Sep 30, 2024 209.50 Mn
Jun 30, 2024 209.05 Mn
Mar 31, 2024 170.45 Mn
Dec 31, 2023 168.64 Mn
Sep 30, 2023 168.18 Mn
Jun 30, 2023 167.13 Mn
Mar 31, 2023 145.74 Mn
Dec 31, 2022 144.44 Mn
Sep 30, 2022 144.03 Mn
Jun 30, 2022 143.72 Mn
Mar 31, 2022 143.57 Mn
Dec 31, 2021 142.62 Mn
Sep 30, 2021 142.44 Mn
API Access

Allogene Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ALLO&period=max&api_key=YOUR_API_KEY